Skip to content
Logo
  • Home
  • Products
  • GastroCHART™
  • Timeline
  • News
  • Where to buy
  • Case Studies
  • Medical Advisory Board
  • Webinars
  • Educational Portal
  • English
    • English
Sep 17

Bedfont announces Dr Jafar Jafari as its first member on the Gastrolyzer Medical Advisory Board

Medical device manufacturer, Bedfont®, appoints Dr Jafari to the advisory board for its gastrointestinal breath monitoring product ‘Gastrolyzer®‘

Bedfont® have specialised in the design and manufacture of breath analysis medical devices for over 40 years. Today, Dr Jafar Jafari will be the first appointment to its Gastrolyzer® Medical Advisory Board.

Dr. Jafari is a highly accomplished consultant clinical scientist in Neurogastroenterology. He serves as both a Senior Lecturer at King’s College London, sharing his expertise with future generations, and as Head of Upper GI Physiology at Guy’s and St Thomas’ Foundation Trust Hospitals, directly impacting patient care. With an MD in Medicine and a PhD in Neurogastroenterology, his research has resulted in over 160 publications in the field. Dr. Jafari’s dedication extends to his specialisation in Hydrogen-Methane as well as C13 GI breath testing, highlighting his ongoing commitment to advancing this area of gastroenterology. Under his leadership, his teams have conducted over 20,000 Hydrogen-Methane breath tests, the majority of which Dr. Jafari has personally reviewed, underscoring his expertise in this area.

The Gastrolyzer® range works by measuring exhaled levels of hydrogen and methane produced when the gut breaks down food. Interpreting these gas levels can help to determine gastrointestinal disorders such as lactose intolerance, IBS (Irritable Bowel Syndrome) and more.

Jason Smith, Managing Director, says, “We are privileged to welcome Dr Jafari into our Bedfont® Family and onto our Gastrolyzer® Medical Advisory Board. We are very fortunate to be able to call upon his extensive knowledge and expertise in the gastrointestinal field.”

Dr Jafar Jafari, adds, “The Gastrolyzer® range provides an instant, non-invasive and easy-to-use method for healthcare professionals and patients to use when investigating gut function. I am privileged to have finally been given this opportunity to contribute to Bedfont®’s GI breath testing campaign.”

Media release date: 16th January 2019

 

Visit our news page for more articles.

1 Comment

  1. GeorgeJom
    December 8, 2019 at 8:11 pm · Reply

    Wonderful website, how do u get all this info?I’ve read a few posts on your site and I really like your writing style. Thanks a million, keep up the good work.
    medical school personal statement

Leave a reply Cancel reply

Your email address will not be published. Required fields are marked *

Contact Details

Bedfont® Scientific Ltd
Station Road, Harrietsham, Maidstone
Kent, ME17 1JA, England

Tel: +44(0)1622 851122
Email: ask@bedfont.com

Products

NObreath®

Smokerlyzer®

Gastrolyzer®

ToxCO®

Medi-Gas Check

Accreditations

ISO 13485:2016

Bedfont EC REP - Emergo

Useful Links

Products

GastroCHART™

Webinars

Medical Advisory Board

Gastrolyzer® COVID-19 Update



White Bedfont text logo

© 1976-2025 Bedfont® Scientific Ltd., all rights reserved | Incorporated in England and Wales under registered number: 1289798

Legal Stuff | Privacy Notice | Help Centre